Its importance in hematological malignancies is becoming clearer [48], [49] and in fact, two groups [50], [51] recently demonstrated that modulation of the NF-κB pathway sensitized leukemic cells to chemotherapy and inhibited leukemia cells growth, respectively. This evidence concerns the gene NFKB1 and hematologic disorder.